A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Active, not recruiting · NCT06508021 · Registry updated 2025-10-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) | Foot Deformities, Hallux Valgus, Inflammation, Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fibrodysplasia ossificans progressiva, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 2 / Phase 3 | 2025-10-14 | NCT06508021 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ashibio Inc | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic | Rochester | United States | 664 |
| University of California San Francisco (UCSF) | San Francisco | United States | 13 |
| University of Pennsylvania - Perelman Center for Advanced Medicine | Philadelphia | United States | 5 |